Singapore: Crystal Pharmatech is going to open its laboratories in China in order to provide customized, materials scie...
Singapore: ShangPharma, a China-based pharmaceutical and biotechnology research and development outsourcing company, cel...
Singapore: Breakthrough Prize in Life Sciences Foundation has opened its process of online nomination for the 2014 prize...
Singapore: Australian drug discovery firm, Bionomics, has received positive results in the phase I clinical trial of its...
Singapore: A study by University of Michigan Comprehensive Cancer Center researchers demonstrated that a new drug has dr...
Singapore: Japan-based pharmaceutical company Shionogi has launched its new European Headquarters in London, UK, to be c...
Singapore: US-based Tetraphase Pharmaceuticals has received approval from US FDA for its lead antibiotic product candida...
Singapore: Clinical stage biopharmaceutical company, Ambrx and China's Zhejiang Medicine (ZMC) have formed a collaborati...
Singapore: Novartis plans to ship around 30 million doses of its influenza vaccines including Fluvirin and Flucelvax to ...
Singapore: The US FDA has given a warning to Dr Bernard Doft, a phase III investigator of Genentech's Lucentis macular d...
Singapore: Pall Corporation, a developer of filtration, separation and purification technology, has decided to acquire A...
Singapore: Cervarix has now been approved for use in females aged nine-to-25 years to prevent persistent infection, prem...
Singapore: Australian clinical research organization, Novotech, has partnered with Korea Drug Development Fund (KDDF) to...
Singapore: Kinex Pharmaceuticals executed a license agreement with Xiangxue Pharmaceuticals granting Xiangxue Pharmaceut...
Singapore: Alchemia, Australia based drug discovery and development company, has appointed Mr. Santo J. Costa as non-exe...
Singapore: Australian company Bionomics and Merck Serono, a division of Merck, Darmstadt Germany, have mutually ended t...
Singapore: A map of avian influenza (H7N9), comprising of bird migration patterns and estimations of poultry production ...
Singapore: Alchemia signed a multi-target, drug discovery collaboration with AstraZeneca. The collaboration includes the...
Singapore: Japan-based Takeda Pharmaceutical and Amsterdam-based Norgine has received Japanese Ministry of Health, Labo...
Singapore: Eli Lilly and Company published data from a phase III trial comparing the effects of FORTEO (teriparatide, rD...
Singapore: Japanese major Takeda Pharmaceutical has said that the China's State Food and Drug Administration (SFDA) has ...
Singapore: Aveo Oncology and Astellas Pharma announced overall survival (OS) for tivozanib, an investigational agent, fr...
Singapore: Europe-based Bone Therapeutics, a biopharmaceutical company focused on innovative cell therapy products for t...
Singapore: Japan's Kanagawa Prefecture's Global Collaboration Center for Life Innovation (GCC) and the Agency for Scienc...
Singapore: Cancer is the biggest cause of mortality worldwide as the killer disease claimed an estimated 8.2 million liv...
Singapore: US-based Protagonist Therapeutics and Australia-based Ironwood Pharmaceuticals expanded their research collab...
Singapore: National Institute of Health and Clinical Excellence (NICE) has decided to recommend Bristol-Myers Squibb's Y...
Singapore: National Cancer Centre Singapore (NCCS) and Clearbridge BioMedics, in partnership with the Pathology Departme...
Singapore: Singapore-based TauRx Pharmaceuticals recieved equity investment of $10.5 million from Toronto's Dundee Corpo...
Singapore: AbbVie's investigational direct-acting antiviral (DAA) combination with and without ribavirin for the treatme...
Singapore: The National Institutes of Health (NIH), US, has launched three projects that will focus on development of t...
Singapore: Innate Immunotherapeutics, a New Zealand-based company, will raise further funds in the second half of 2012 t...
Singapore: The Scripps Research Institute (TSRI) and Takeda Pharmaceutical plan to expand their recent research collabo...
Singapore: Prima BioMed has commenced recruitment of patients into the Canvas (Cancer Vaccine Study) trial in Europe. P...
Singapore: Bionomics entered in an agreement with Merck, which is also known as Merck Sharp and Dohme outside the US and...
Singapore: Bayer HealthCare started enrolling patients in an international phase II/III trial called PROTECT VIII that i...
‎Singapore: China based pharmaceutical company, Yabao Pharmaceutical, has partnered with Eli Lilly to co-develop L...
‎Singapore: ScinoPharm Taiwan and Taiwan-listed, China-based company, Coland, have formed a strategic alliance to ...
Singapore: ViroMed, a leading biotechnology company, announced the final enrollment and administration of 105 patients f...
Singapore: By scouring the DNA of thousands of patients, researchers at Broad Institute, Massachusetts General Hospital,...
Singapore: The European Medicines Agency (EMA) has accepted the marketing authorization application for review of an aty...
‎Singapore: China-based Chipscreen Biosciences announced the achievement of the primary endpoint in the pivotal, r...
Singapore: US Food and Drug Administration has affirmed Boehringer Ingelheim's Pradaxa 150mg superior in reducing ischem...
Singapore: Global pharmaceutical company, Sanofi has temporarily withdrawn new drug application (NDA) for lixisenatide i...
Singapore: Global biopharmaceutical company Amgen plans to acquire all the outstanding shares of Onyx Pharmaceuticals fo...
Singapore: The TRILOGY ACS study, a phase III trial comparing prasugrel plus aspirin to clopidogrel plus aspirin in pati...
Singapore: Astellas Pharma, Japan's pharmaceutical giant with net sales of $10.7 billion and net income of $881 million ...
Singapore: GlaxoSmithKline (GSK) and A*STAR's Institute of Chemical and Engineering Sciences (ICES) have signed a five-y...
Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA), has recieved Therapeutic Good...
Singapore: Australian pharmaceutical company Pharmaxis' research projects conducted in conjunction with the University o...
Singapore: Belgian biotechnology company Cardio3 BioSciences (C3BS) has received authorization from the Belgian Federal ...
Singapore: Australian regenerative drug company, Mesoblast, is planning to expand its global manufacturing base and the ...
Singapore: US based Sanford-Burnham Medical Research Institute and Japan's Daiichi Sankyo have formed a three year disco...
Singapore: Boehringer Ingelheim and Eli Lilly have initiated phase IIIb trial to evaluate the glycaemic efficacy and saf...
Singapore: Taiwan Liposome Company's multi-mechanistic anti-cancer new chemical entity Lipotecan has been accepted into ...
Singapore: AstraZeneca has signed a research collaboration with Fudan University, one of China's leading academic instit...
Singapore: Phylogica, a leading Australian peptide drug discovery company, has extended its collaboration with Janssen B...
Singapore: Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has provided Ast...
Singapore: US-based Regeneron Pharmaceuticals has acquired exclusive rights to two families of novel antibodies from San...
Singapore: Israel-based Teva Pharmaceutical and Canada-based Xenon Pharmaceuticals have entered into a collaborative dev...
Singapore: Ironwood Pharmaceuticals and AstraZeneca Pharmaceuticals have announced the initiation of a phase III clinica...
Singapore: NanoMaterials Technology (NMT), a Singapore based company, has signed an exclusive material supply agreement ...
A meeting between Dr Teo Soo Hwang, current CEO of AseaCyte; Dr Lee Hong Boon from Cancer Research Initiatives Foundatio...
Singapore: Specialised Therapeutics Australia (STA) is going to publish abstracts related to its phase III metastatic me...
Singapore: Japan-based Astellas Pharma and US-headquartered Ambit Biosciences are ending their collaboration for joint d...
Singapore: Roche has launched FLOW system, a user defined system for workflow chain from primary sample handling to qPCR...
Singapore: WHO and Global Fund to Fight AIDS, TB and Malaria have stressed on strains of tuberculosis with resistance to...
Singapore: US-based Edison Pharmaceuticals has entered into a strategic alliance valued up to $4.295 billion with Japan'...
Singapore: US-based Gilead Sciences has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Dev...
Singapore: GlaxoSmithKline has recieved European Commission (EC) marketing authorisation for Mekinist (trametinib) as a ...
Singapore: Brisbane drug discovery and development company Alchemia announces that Mr Charles Walker has been appointed...
Singapore: Merck Millipore is boosting its portfolio for drug bioavailability, including products for all types of dosag...
Singapore: Singapore has announced 8 biomedical sciences research programmes to advance understanding and treatment of d...
Singapore: Boehringer Ingelheim, one of the world's leading pharmaceutical companies, will acquire the global rights of ...
Singapore: China's biomedical sector is rapidly transforming itself from a manufacturing base to an innovation hub, inve...
Singapore: Japan-based Astellas Pharma has received US FDA approval for Astagraf XL (tacrolimus extended-release capsule...
Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry ser...
Singapore: National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) has provi...
Singapore: Janssen Biotech has entered into a license agreement with Astellas Pharma for the worldwide development and c...
Singapore: European Commission has approved Exjade (deferasirox) for the treatment of chronic iron overload requiring ch...
Singapore: CSL Behring's novel recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP...
Singapore: Arthritis Foundation appointed Dr John Vernachio as vice president of research, effective April 15. In his ne...
Singapore: GVK Biosciences is extending its Clinical Biomarker Database (Gobiom) license to the Biomarker Qualification ...
Singapore: Japanese firm Otsuka Pharmaceutical and global firm H Lundbeck have submitted a New Drug Application (NDA) to...
Singapore: Long-term treatment with the type 2 diabetes drug metformin improves health and longevity of male mice when s...
In the last few years, biotech companies in Korea have targeted innovation in drug development and are building platform...
Singapore: German drug major Boehringer Ingelheim has planned to build a biologics plant in Shanghai, China, to offer co...
Singapore: Researchers at Singapore's Institute of Bioengineering and Nanotechnology (IBN) and California's IBM Research...
Singapore: Novartis highlighted that the results of a global phase III study showed that Afinitor (everolimus) did not e...
Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, submitted a pre-Investigational New Drug (...
Singapore: Australian drug delivery company, Phosphagenics, has raised $19.3 million via a placement of $16.3 million to...
Singapore, July 09, 2012: Bayer HealthCare has started to enroll patients in an international Phase II/III trial to eval...
Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 m...
Singapore: Astellas Pharma signed a license agreement with Janssen Biotech under which Janssen has an exclusive right to...
Singapore: Eisai announced that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory C...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem has received notice of Allowanc...
Minoryx Therapeutics, a drug development company specialized in the discovery and development of new drugs for orphan di...
Apollo Therapeutics, the collaborative venture between three world-leading UK universities and three global pharmaceutic...
US based Pelical BioThermal which is a global leader providing the broadcast and most innovative range of temperature-co...
Singapore: The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, an...
